Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
108.4 USD | -0.21% | -4.02% | -11.69% |
05-13 | US reclassification could drive fresh research funding into pot sector | RE |
05-07 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.69% | 6.85B | |
+34.35% | 705B | |
+31.18% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.26% | 238B | |
-3.72% | 210B | |
+10.19% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals plc Presents at Bank of America 2022 Healthcare Conference, May-10-2022 12